Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yu, Melissa
NCT05397639 / 2021-003405-22: Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type	Recruiting	3	375	Europe, US, RoW	Masupirdine 50 mg, SUVN-502, Masupirdine 100 mg, Placebo	Suven Life Sciences Limited, Suven Life Sciences Ltd	Agitation, Alzheimer's Type Dementia	01/25	01/25
ENVISION, NCT05310071 / 2022-001671-14: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease	Terminated	3	1027	Europe, Canada, Japan, US, RoW	Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo	Biogen, Biogen Idec Research Limited	Alzheimer's Disease	08/24	08/24
START, NCT05531656: A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	Recruiting	2	540	US	CT1812, Study Drug Active, Placebo, Matching Placebo	Cognition Therapeutics, National Institute on Aging (NIA), Alzheimer's Clinical Trials Consortium	Early Alzheimer's Disease	04/27	04/27
NCT06139354: Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault	Recruiting	N/A	45	US	decision aid	University of Arkansas, University of California, Davis, District of Columbia Forensic Nurse Examiners	Hiv	06/25	06/25
POINTER, NCT03688126: U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk	Active, not recruiting	N/A	2000	US	Self-Guided Lifestyle Intervention, Self-Guided, Structured Lifestyle Intervention	Wake Forest University Health Sciences, Alzheimer's Association	Alzheimer Disease	07/25	07/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yu, Melissa
NCT05397639 / 2021-003405-22: Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type	Recruiting	3	375	Europe, US, RoW	Masupirdine 50 mg, SUVN-502, Masupirdine 100 mg, Placebo	Suven Life Sciences Limited, Suven Life Sciences Ltd	Agitation, Alzheimer's Type Dementia	01/25	01/25
ENVISION, NCT05310071 / 2022-001671-14: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease	Terminated	3	1027	Europe, Canada, Japan, US, RoW	Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo	Biogen, Biogen Idec Research Limited	Alzheimer's Disease	08/24	08/24
START, NCT05531656: A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	Recruiting	2	540	US	CT1812, Study Drug Active, Placebo, Matching Placebo	Cognition Therapeutics, National Institute on Aging (NIA), Alzheimer's Clinical Trials Consortium	Early Alzheimer's Disease	04/27	04/27
NCT06139354: Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault	Recruiting	N/A	45	US	decision aid	University of Arkansas, University of California, Davis, District of Columbia Forensic Nurse Examiners	Hiv	06/25	06/25
POINTER, NCT03688126: U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk	Active, not recruiting	N/A	2000	US	Self-Guided Lifestyle Intervention, Self-Guided, Structured Lifestyle Intervention	Wake Forest University Health Sciences, Alzheimer's Association	Alzheimer Disease	07/25	07/25